There's a Better Way to Fix Remote Monitoring: Coalition Proposes Registration and Accountability in Place of CMS's 2027 Proposed Changes
There's a Better Way to Fix Remote Monitoring: Coalition Proposes Registration and Accountability in Place of CMS's 2027 Proposed Changes
PR Newswire
GREENVILLE, S.C., Aug. 6, 2026
GREENVILLE, S.C., Aug. 6, 2026 /PRNewswire/ -- ChartSpan, one of the nation's largest care management and remote monitoring organizations, leads the Save Remote Patient Monitoring Coalition in urging the Centers for Medicare & Medicaid Services (CMS) to reconsider the RPM provisions in the 2027 Physician Fee Schedule Proposed Rule. Instead of these provisions, the coalition proposes a new registration system to give CMS greater oversight of third-party RPM vendors.

In its 2024 report on RPM, "Additional Oversight of Remote Patient Monitoring in Medicare Is Needed," the HHS Office of Inspector General raised legitimate questions about program integrity, including whether CMS has enough visibility into who furnishes the service under general supervision of the provider. The coalition shares that commitment to program integrity.
Therefore, the coalition proposes a Registered RPM Organization (RRO) framework: a supplier-registration category under which every organization furnishing RPM enrolls with CMS, meets accreditation standards, is identified on every claim it supports, submits to outlier-focused auditing with due-process safeguards, and reports standardized outcomes each year. The approach is built on frameworks CMS has used successfully before, including durable medical equipment supplier accreditation, Medicare Shared Savings Program participation agreements, and Medicare Diabetes Prevention Program suppliers.
Most primary care and rural practices cannot staff continuous monitoring in-house. A third-party organization is their only option for remote patient monitoring, and registration and accreditation would hold those vendors to enforceable, auditable standards.
The clinical case for protecting access is strong. ChartSpan found 55.3 percent hypertension control, up from a 46 percent baseline, at a nine-site health system serving patients, an average 0.9-point HbA1c reduction across 6,463 members in a remote glucose monitoring program, and improved ejection fraction in 66 percent of monitored heart failure patients with follow-up data.
"Save Remote Patient Monitoring supports strong program integrity and believes the answer is to make RPM organizations visible and accountable, not to price a proven, preventive benefit out of reach for the patients who need it most," said Jon-Michial Carter, co-founder and Chief Growth Officer of ChartSpan.
You can read the full policy paper and join the Save Remote Patient Monitoring Coalition at saveremotepatientmonitoring.com. Public comments on the CY 2027 Physician Fee Schedule Proposed Rule are due to CMS by September 14, 2026.
About ChartSpan
ChartSpan is a leading care management company dedicated to scaling the impact of preventive care. Through specialized clinical services, expert care teams, and supportive technology infrastructure, ChartSpan helps organizations improve patient outcomes, increase revenue, and reduce the burden of chronic disease. For more information, visit www.chartspan.com.
About the Save Remote Patient Monitoring Coalition
The Save Remote Patient Monitoring Coalition is an alliance of RPM organizations, clinicians, health systems, and patients who deliver and depend on remote monitoring. The coalition supports strong Medicare program integrity and advocates for accountability-based reforms that preserve patient access. Learn more and join at saveremotepatientmonitoring.com.
Media Contact
Taylor Davidson
Content Marketing Manager
ChartSpan
taylor.davidson@chartspan.com

SOURCE ChartSpan
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
2 Undervalued Stocks to Buy Before They Rebound
